BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
CALSCALE:GREGORIAN
PRODID:-//WordPress - MECv6.5.5//EN
X-ORIGINAL-URL:https://crsic.org/
X-WR-CALNAME:Controlled Release Society
X-WR-CALDESC:CRS Indian Local Chapter is an organization for the promotion and development of Novel Drug Delivery Systems
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-PUBLISHED-TTL:PT1H
X-MS-OLK-FORCEINSPECTOROPEN:TRUE
BEGIN:VEVENT
CLASS:PUBLIC
DTSTART;TZID=Asia/Dili:20200502T160000
DTEND;TZID=Asia/Dili:20200502T180000
DTSTAMP:20201124T111700
UID:MEC-2d405b367158e3f12d7c1e31a96b3af3@crsic.org
CREATED:20201124
LAST-MODIFIED:20201124
PRIORITY:5
TRANSP:OPAQUE
SUMMARY:Vaccine Manufacturing: Opportunities and Challenges
DESCRIPTION:Amidst the lockdown due to COVID Pandemic, Indian Chapter of CRS organized its very first National webinar titled “Vaccine Manufacturing: Opportunities and Challenges” on 2nd May 2020. Dr. S. S. Pisal was an invited speaker for this webinar. Dr. Pisal is currently working as a Director -R&D & Manufacturing at Serum Institute of India, Pvt. Ltd., Pune. Serum institute is one of the largest vaccines manufacturers of the globe.\nWith the long standing experience in the field of vaccine formulation development, upstream/downstream processing of vaccines, Dr. Pisal delivered an insightful and enlightening talk on the theme of the webinar. He explained the intricate details of vaccine development focusing on lyophilization process, one of the most crucial steps during vaccine manufacturing. The national webinar was well received by more than 100 participants.\n
URL:https://crsic.org/events/vaccine-manufacturing-opportunities-and-challenges/
CATEGORIES:National Workshop
END:VEVENT
END:VCALENDAR